ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 191 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,955 | +27.8% | 69,066 | +1.3% | 0.08% | +32.8% |
Q2 2023 | $26,579 | -7.5% | 68,200 | -11.6% | 0.06% | -12.9% |
Q1 2023 | $28,747 | -0.3% | 77,157 | +1.4% | 0.07% | -6.7% |
Q4 2022 | $28,834 | -99.9% | 76,113 | -0.8% | 0.08% | +1.4% |
Q3 2022 | $27,078,000 | -8.1% | 76,697 | -1.4% | 0.07% | -5.1% |
Q2 2022 | $29,470,000 | +13.4% | 77,782 | -5.6% | 0.08% | +52.9% |
Q1 2022 | $25,983,000 | -4.5% | 82,405 | +6.1% | 0.05% | -1.9% |
Q4 2021 | $27,196,000 | +39.7% | 77,660 | +20.4% | 0.05% | +30.0% |
Q3 2021 | $19,472,000 | -26.9% | 64,477 | -27.1% | 0.04% | -25.9% |
Q2 2021 | $26,625,000 | +10.3% | 88,436 | +0.9% | 0.05% | +1.9% |
Q1 2021 | $24,137,000 | -13.4% | 87,647 | -7.6% | 0.05% | -18.5% |
Q4 2020 | $27,884,000 | +27.8% | 94,815 | +14.1% | 0.06% | +12.1% |
Q3 2020 | $21,824,000 | +220.5% | 83,133 | +175.0% | 0.06% | +190.0% |
Q2 2020 | $6,809,000 | +123.0% | 30,229 | +30.4% | 0.02% | +81.8% |
Q1 2020 | $3,054,000 | – | 23,180 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |